Effects of GLP-1 Agonists on mortality and arrhythmias in patients with Type II diabetes

Effects of GLP-1 Agonists on mortality and arrhythmias in patients with Type II diabetes

Background: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) are frequently used for the management of diabetes. The impact of GLP-1 RA on cardiovascular outcomes is unclear. We aim to assess the effect of GLP-1 RA on mortality, atrial and ventricular arrhythmias, and sudden cardiac death in pat...

Full description

Bibliographic Details
Main Authors: Mohammed A. Al-Sadawi, Faisal M. Aslam, Michael Tao, Mahmoud Alsaiqali, Ibrahim O. Almasry, Roger Fan, Eric J. Rashba, Abhijeet Singh
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
GLP-1 agonists
Sudden cardiac death
Arrhythmias
Outcomes
Mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906723000490

Internet

http://www.sciencedirect.com/science/article/pii/S2352906723000490

Similar Items